Arthur J. Gallagher & Co. Announces Fourth Quarter 2025 Earnings Release And Conference Call Date
Werte in diesem Artikel
ROLLING MEADOWS, Ill., Jan. 8, 2026 /PRNewswire/ -- Arthur J. Gallagher & Co. (NYSE: AJG) will release its fourth quarter 2025 earnings after the market closes on Thursday, January 29, 2026. A printer-friendly format will be available on the company's website shortly thereafter.
In conjunction with this release, J. Patrick Gallagher, Jr., Chairman and CEO, will host a conference call on Thursday, January 29, 2026 at 5:15 pm ET/4:15 pm CT.
The conference call will be broadcast live through Gallagher's website at www.ajg.com and a conference call replay will be available on the company's website approximately two hours after the broadcast. The replay can be accessed by going to Investor Relations and clicking on Events & Presentations.
Arthur J. Gallagher & Co. (NYSE: AJG), a global insurance brokerage, risk management and consulting services firm, is headquartered in Rolling Meadows, Illinois. Gallagher provides these services in approximately 130 countries around the world through its owned operations and a network of correspondent brokers and consultants.
Contact:
Ray Iardella
VP - Investor Relations
(630) 285-3661 – Ray_Iardella@ajg.com
View original content:https://www.prnewswire.com/news-releases/arthur-j-gallagher--co-announces-fourth-quarter-2025-earnings-release-and-conference-call-date-302656815.html
SOURCE Arthur J. Gallagher & Co.
Übrigens: Arthur J. Gallagher und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Arthur J. Gallagher
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Arthur J. Gallagher
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|